Effect of Prostaglandins and Hormones on Cyclic AMP Formation in Rat Hepatomas and Liver Tissue

Overview

Journal Br J Cancer

Specialty Oncology

Date 1978 Dec 1

PMID 217400

Citations 3

Authors

G O Bronstad

T Christoffersen

E J Johansen

I Oye

Affiliations

Soon will be listed here.

Abstract

The formation of cyclic AMP was studied in normal liver, subcutaneous hepatomas derived from MH1C1 cells, and premalignant liver and primary hepatomas induced by the carcinogens 2-acetylaminofluorene (AAF) and 4-dimethylamino-azobenzene (DAB). While only very slight effects of prostaglandins (PG) were seen in slices of normal liver, all the hepatomas responded strongly to PGE1 and PGE2. The hepatomas also had increase PGE1-sensitive adenylate-cyclase activity. PGF1alpha and PGF2alpha did not increase the cAMP level significantly either in the liver or in the hepatomas. During AAF carcinogenesis the response to PGE1 increased slightly during the carcinogen feeding, and was greatly elevated only in the fully developed hepatomas. This is in contrast to the increase in adrenalin response seen during carcinogenesis, which starts much earlier, and reaches a peak value within 8--10 weeks. It is concluded that various hepatomas have elevated responsiveness to PGE1 and PGE2 as well as to adrenalin, but the course of change in the tissues' ability to respond to these agents during carcinogenesis is very different.

Citing Articles

Human hepatocellular cancers show decreased prostaglandin E1 binding capacity.

Virgolini I, Sinzinger H, Muller C, Hermann M Br J Cancer. 1989; 59(3):407-9.

PMID: 2539179 PMC: 2247058. DOI: 10.1038/bjc.1989.81.

Decrease of prostaglandin I2 binding sites in thyroid cancer.

Virgolini I, Hermann M, Sinzinger H Br J Cancer. 1988; 58(5):584-8.

PMID: 2464364 PMC: 2246842. DOI: 10.1038/bjc.1988.264.

Seglen P, Gerlyng P Environ Health Perspect. 1990; 88:197-205.

PMID: 2272315 PMC: 1568024. DOI: 10.1289/ehp.9088197.

References

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

HICKIE R, Thompson W, Strada S, MORRIS H, Robison G . Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver. Cancer Res. 1977; 37(10):3599-606. View

Achar S, Strada S, SANDERS R, Pledger W, Thompson W, Robison G . Sonication as a tool for the study of adenylyl cyclase activity. J Cyclic Nucleotide Res. 1977; 3(3):189-98. View

Friedman D . Role of cyclic nucleotides in cell growth and differentiation. Physiol Rev. 1976; 56(4):652-708. DOI: 10.1152/physrev.1976.56.4.652. View

Leffert H, Koch K, Rubalcava B . Present paradoxes in the environmental control of hepatic proliferation. Cancer Res. 1976; 36(11 Pt. 2):4250-5. View

Richardson U, TASHJIAN Jr A, Levine L . Establishment of a clonal strain of hepatoma cells which secrete albumin. J Cell Biol. 1969; 40(1):236-47. PMC: 2107590. DOI: 10.1083/jcb.40.1.236. View

Boyd H, LOUIS C, Martin T . Activity and hormone responsiveness of adenyl cyclase during induction of tumors in rat liver with 3'-methyl-4-dimethylaminoazobenzene. Cancer Res. 1974; 34(7):1720-5. View

Salomon Y, Londos C, Rodbell M . A highly sensitive adenylate cyclase assay. Anal Biochem. 1974; 58(2):541-8. DOI: 10.1016/0003-2697(74)90222-x. View

Emmelot P, Bos C . Studies on plasma membranes. XIV. Adenyl cyclase in plasma membranes isolated from rat and mouse livers and hepatomas, and its hormone sensitivity. Biochim Biophys Acta. 1971; 249(1):285-92. DOI: 10.1016/0005-2736(71)90106-4. View

10.

Christoffersen T, Morland J, Osnes J, Elgjo K . Hepatic adenyl cyclase: alterations in hormone response during treatment with a chemical carcinogen. Biochim Biophys Acta. 1972; 279(2):363-6. DOI: 10.1016/0304-4165(72)90153-5. View

11.

ALLEN D, Munshower J, MORRIS H, Weber G . Regulation of adenyl cyclase in hepatomas of different growth rates. Cancer Res. 1971; 31(5):557-60. View

12.

Chayoth R, EPSTEIN S, Field J . Glucagon and prostaglandin E1 stimulation of cyclic adenosine 3', 5'-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats. Cancer Res. 1973; 33(8):1970-4. View

13.

Christoffersen T, Morland J, Osnes J, Oye I . Development of cyclic AMP metabolism in rat liver. A correlative study of tissue levels of cyclic AMP, accumulation of cyclic AMP in slices, adenylate cyclase activity and cyclic nucleotide phosphodiesterase activity. Biochim Biophys Acta. 1973; 313(2):338-49. DOI: 10.1016/0304-4165(73)90033-0. View

14.

Tomasi V, Rethy A, Trevisani A . Soluble and membrane-bound adenylate cyclase activity in Yoshida ascites hepatoma. Life Sci II. 1973; 12(4):145-50. DOI: 10.1016/0024-3205(73)90206-3. View

15.

Brown H, Chattopadhyay S, MORRIS H, Pennington S . Adenyl cyclase activity in Morris hepatomas 7777, 7794A, and 9618A. Cancer Res. 1970; 30(1):123-6. View

16.

Feher I, GIDALI J . Prostaglandin E2 as stimulator of haemopoietic stem cell proliferation. Nature. 1974; 247(5442):550-1. DOI: 10.1038/247550a0. View

17.

Chayroth R, Epstein S, Field J . Increased cyclic AMP levels in malignant hepatic nodules of ethionine treated rats. Biochem Biophys Res Commun. 1972; 49(6):1663-70. DOI: 10.1016/0006-291x(72)90534-7. View

18.

Gaudernack G, Rugstad H, Hegna I, Prydz H . Synthesis of serum proteins by a clonal strain of rat hepatoma cells. Exp Cell Res. 1973; 77(1):25-30. DOI: 10.1016/0014-4827(73)90548-x. View

19.

Macmanus J, Franks D, YOUDALE T, Braceland B . Increases in rat liver cyclic AMP concentrations prior to the initiation of DNA synthesis following partial hepatectomy or hormone infusion. Biochem Biophys Res Commun. 1972; 49(5):1201-7. DOI: 10.1016/0006-291x(72)90596-7. View

20.

THOMAS E, Murad F, LOONEY W, MORRIS H . Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate: concentrations in Morris hepatomas of different growth rates. Biochim Biophys Acta. 1973; 297(2):564-7. DOI: 10.1016/0304-4165(73)90106-2. View